Cytosorbents (CTSO) EBITDA Margin Growth (5y) (2016 - 2026)
Cytosorbents (CTSO) EBITDA Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.38 Bn | 196.77 Bn | 7.27 Bn |
| 2 | Stryker | 126.28 Bn | 122.80 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.10 Bn | 73.56 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.67 Bn | 47.42 Bn | 1.35 Bn |
| 6 | Dexcom | 35.07 Bn | 33.12 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Cytosorbents | 23.55 Mn | 19.13 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,357.00 |
| Mar 31, 2026 | -743.00 |
| Dec 31, 2025 | -2,545.00 |
| Sep 30, 2025 | -1,159.00 |
| Jun 30, 2025 | -392.00 |
| Mar 31, 2025 | -1,608.00 |
| Dec 31, 2024 | 3,600.00 |
| Sep 30, 2024 | 3,625.00 |
| Jun 30, 2024 | 1,787.00 |
| Mar 31, 2024 | 3,074.00 |
| Dec 31, 2023 | -1,669.00 |
| Sep 30, 2023 | -3,622.00 |
| Jun 30, 2023 | 314.00 |
| Mar 31, 2023 | -2,054.00 |
| Dec 31, 2022 | 1,420.00 |
| Sep 30, 2022 | -5,497.00 |
| Jun 30, 2022 | -3,301.00 |
| Mar 31, 2022 | -3,962.00 |
| Dec 31, 2021 | 5,954.00 |
| Sep 30, 2021 | 3,352.00 |